Xiang Zhou - Search Results

Year	Number of Results
1996	1
1997	1
1998	1
2002	8
2003	7
2004	10
2005	16
2006	21
2007	23
2008	29
2009	41
2010	54
2011	59
2012	77
2013	97
2014	96
2015	104
2016	90
2017	109
2018	118
2019	143
2020	221
2021	256
2022	155

1

Ferroptosis as a novel therapeutic target for cardiovascular disease.

Wu X, Li Y, Zhang S, Zhou X. Wu X, et al. Among authors: zhou x. Theranostics. 2021 Jan 1;11(7):3052-3059. doi: 10.7150/thno.54113. eCollection 2021. Theranostics. 2021. PMID: 33537073 Free PMC article. Review.

2

Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis.

Wen W, Chen C, Tang J, Wang C, Zhou M, Cheng Y, Zhou X, Wu Q, Zhang X, Feng Z, Wang M, Mao Q. Wen W, et al. Among authors: zhou x. Ann Med. 2022 Dec;54(1):516-523. doi: 10.1080/07853890.2022.2034936. Ann Med. 2022. PMID: 35118917 Free PMC article.

3

Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.

Liu F, Li L, Xu M, Wu J, Luo D, Zhu Y, Li B, Song X, Zhou X. Liu F, et al. Among authors: zhou x. J Clin Virol. 2020 Jun;127:104370. doi: 10.1016/j.jcv.2020.104370. Epub 2020 Apr 14. J Clin Virol. 2020. PMID: 32344321 Free PMC article.

4

m⁶A RNA Methylation in Cardiovascular Diseases.

Wu S, Zhang S, Wu X, Zhou X. Wu S, et al. Among authors: zhou x. Mol Ther. 2020 Oct 7;28(10):2111-2119. doi: 10.1016/j.ymthe.2020.08.010. Epub 2020 Aug 19. Mol Ther. 2020. PMID: 32910911 Free PMC article. Review.

5

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.

Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, Xie Y, Yan T, Yu T, Sun T, Qian Y, Zhong M, Chen J, Peng Y, Wang C, Zhou X, Liu J, Liu Q, Ma X, Chen YX, Chen H, Fang JY. Hong J, et al. Among authors: zhou x. Gut. 2021 Nov;70(11):2123-2137. doi: 10.1136/gutjnl-2020-322780. Epub 2020 Dec 14. Gut. 2021. PMID: 33318144

6

TMK-based cell-surface auxin signalling activates cell-wall acidification.

Lin W, Zhou X, Tang W, Takahashi K, Pan X, Dai J, Ren H, Zhu X, Pan S, Zheng H, Gray WM, Xu T, Kinoshita T, Yang Z. Lin W, et al. Among authors: zhou x. Nature. 2021 Nov;599(7884):278-282. doi: 10.1038/s41586-021-03976-4. Epub 2021 Oct 27. Nature. 2021. PMID: 34707287 Free PMC article.

7

Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma.

Hao Q, Li J, Zhang Q, Xu F, Xie B, Lu H, Wu X, Zhou X. Hao Q, et al. Among authors: zhou x. Clin Transl Med. 2021 Aug;11(8):e500. doi: 10.1002/ctm2.500. Clin Transl Med. 2021. PMID: 34459128 Free PMC article.

8

Statistical methods for SNP heritability estimation and partition: A review.

Zhu H, Zhou X. Zhu H, et al. Among authors: zhou x. Comput Struct Biotechnol J. 2020 Jun 18;18:1557-1568. doi: 10.1016/j.csbj.2020.06.011. eCollection 2020. Comput Struct Biotechnol J. 2020. PMID: 32637052 Free PMC article. Review.

9

Cereblon enhancer methylation and IMiD resistance in multiple myeloma.

Haertle L, Barrio S, Munawar U, Han S, Zhou X, Vogt C, Fernández RA, Bittrich M, Ruiz-Heredia Y, Da Viá M, Zovko J, Garitano-Trojaola A, Bolli N, Ruckdeschel A, Stühmer T, Chatterjee M, Kull M, Krönke J, Agirre X, Martin-Subero JI, Raab P, Einsele H, Rasche L, Martinez-Lopez J, Haaf T, Kortüm KM. Haertle L, et al. Among authors: zhou x. Blood. 2021 Nov 4;138(18):1721-1726. doi: 10.1182/blood.2020010452. Blood. 2021. PMID: 34115836

10

FBW7 suppresses ovarian cancer development by targeting the N⁶-methyladenosine binding protein YTHDF2.

Xu F, Li J, Ni M, Cheng J, Zhao H, Wang S, Zhou X, Wu X. Xu F, et al. Among authors: zhou x. Mol Cancer. 2021 Mar 3;20(1):45. doi: 10.1186/s12943-021-01340-8. Mol Cancer. 2021. PMID: 33658012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results